Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Host Daniel Litwin on Why Vendors Should Secure DHA/DLA Contracts

When it comes to procurement at the highest level, contracts can become a complicated business. Medical grade equipment for the military always requires next-level due diligence throughout the ordering process and, because of this, procurement can often take months to a year to finalize. With internal solutions like Electronic Catalog (ECAT), there are now ways…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Host Daniel Litwin on Why Vendors Should Secure DHA/DLA Contracts

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

When it comes to procurement at the highest level, contracts can become a complicated business. Medical grade equipment for the military always requires next-level due diligence throughout the ordering process and, because of this, procurement can often take months to a year to finalize. With internal solutions like Electronic Catalog (ECAT), there are now ways to not only save money on procurement but also time.

Bob Charron sits down on the with host of the Champions of Care, a podcast to discuss the differences between different major contracts and their solutions such as Defense Health Agency (DHA), Defense Logistics Agency (DLA), and ECAT. He goes in depth on how these solutions streamline processes that once took 60-90 minutes to complete.

The world of procurement is one that leaves no stone unturned to get equipment in the hands of customers and because of that, the process would often take a long time. Charron talks about how this problem with efficiency led to changing how vendors did business. “Initially it all started when we needed some sort of vehicle to procure more efficiently and to get the best possible cost from the vendor community,” he said.

This change in procurement came on the heels of new innovations that made improving old systems far easier. In using new tools and means of communication, solutions like ECAT were able to be born. Charron talks about this change, “We’re seeing as time has evolved, technology has improved, communication has improved, and access to information has improved, I think there’s sort of a move to streamline it further.”

Thanks to solutions like ECAT and new contracts, equipment can get into the hands of customers without a long delay. The process is now also streamlined for easier ordering, using the essential tools to pull off procurement while eliminating the old tools that take up time and money for little to no use.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512